If you read the article, the patients were all negative for C. Diff. so Vancocin wouldn't be prescribed anyway. Doesn't appear to be a threat unless they test it on patients with C.Diff and get positive results.
Nice DD. Have you convinced yourself that Vphm is a good stock?? Bobwins.